Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2101094	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-05-11					view
JYHB2002482	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-12-03	AbbVie Corporation	Abbvie Corporation	Certificate Issued	2021-02-02	view
JYHB2000601	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs	Supplementary Application	2020-05-20	AbbVie Corporation	Abbvie Corporation	Filed	2020-06-01	view
JXHL1900293	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs(2.4)	Import Drug Application	2019-11-06	AbbVie Corporation	Abbvie Corporation	In Review	2019-11-05	view
JYHB1901015	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs	Supplementary Application	2019-08-27	AbbVie Corporation	Abbvie Corporation	Certificate Issued	2019-12-19	view
JYHB1900913	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs	Supplementary Application	2019-07-29	AbbVie Corporation	Abbvie Corporation	Certificate Issued	2019-11-28	view
JXHS1800019	格卡瑞韦哌仑他韦片	glecaprevir;pibrentasvir	Tablet	Chemical Drugs(5.1)	Import Drug Application	2018-04-16	AbbVie Corporation	Abbvie Corporation	Certificate Issued	2019-05-17	view